GenScript growth playbook

Load the chat widget only when a visitor clicks the chat button (show a lightweight button until then), replace the YouTube embed with a thumbnail that loads the player on click, set long cache lifetimes on static files, and compress the page images. Re-test with PageSpeed, then watch the Chrome UX Report for 28 days and compare quote starts before and after.

Scientists click from email, LinkedIn and search on phones between experiments; a page that responds slowly loses them before the quote form. Every campaign the new hire runs pays more when the landing page is fast, and the fix is mostly configuration.

[ ] Chat widget and calling module load only on click
[ ] YouTube embed replaced by a click-to-play thumbnail
[ ] Long cache lifetimes on /gsfiles/ scripts, styles and images
[ ] Images compressed and sized for mobile
[ ] Tags in Google Tag Manager reviewed and unused ones removed
[ ] PageSpeed re-run on mobile
[ ] Chrome UX Report checked after 28 days

• Fewer chats started

  Keep the chat button visible; measure chats per visit.

• Template shared across pages

  Test on gene synthesis first, then roll out.

• Google PageSpeedGene synthesis service page on mobile (PageSpeed, October 21, 2026): performance 28, 7.9 MB, Largest Contentful Paint 11.8 s and 10.1 s of blocked main thread in the lab. Real visitors fail Core Web Vitals: Largest Contentful Paint 3.0 s and Interaction to Next Paint 264 ms at the 75th percentile. The live-chat widget (including a voice-calling module) is the largest script cost, about 6 seconds of script time and 1.5 MB of unused code, followed by an embedded YouTube player loaded with the page.Source
• HiringIntegrated Campaign Manager, Life Sciences Marketing (remote US, posted October 7, 2026) and a Marketing Campaigns Manager, International (same brief, still open): "transform business needs into marketing campaigns" with "omni-channel content development, and evaluation methods", "Build the storytelling of the GenScript LSG brand", and "Monitor the progress and analyze the effectiveness of marketing campaigns".Source
• News coverageFirst-half 2026 results (August 18, 2026): revenue about US$404.2 million, up 27.3%; Life Science Group revenue about US$319.0 million, up 28.8%; Gene-to-Protein was about 66% of Life Science Group revenue and "the primary growth engine"; the AI-enabled drug discovery business "doubled year over year"; ProBio revenue up 34.2% and new orders up 54%. GenScript has about 6,165 employees and has served more than 200,000 customers in over 100 countries.Source
• Google PageSpeedHomepage on mobile: performance 29, 9.0 MB page weight (4.6 MB of images), lab Largest Contentful Paint 15.5 s on a carousel banner image, and about 4.1 MB of files served without efficient cache lifetimes. The homepage itself passes for real visitors (LCP 1.8 s), but the site as a whole fails Core Web Vitals: Largest Contentful Paint 2.7 s and Interaction to Next Paint 213 ms, with load time 13% slower than a year earlier. The viewport tag blocks zooming on phones.Source

Rewrite the homepage title and description around the two messages that drive revenue (Gene-to-Protein and AI drug discovery validation), add a share image, and do the same for the top 20 service pages. Keep each title under 60 characters.

Search results and link previews are the first thing a campaign audience sees; matching the new positioning raises click-through and makes the story consistent for AI summaries.

• Losing gene synthesis rankings

  Keep "gene synthesis" in the title.

• Your websiteHomepage title: "GenScript - Scripting Possibilities - The leader in molecular cloning and gene synthesis, peptide synthesis, protein and antibody engineering"; meta description: "a leading biotech company focusing exclusively on early drug discovery and development services"; hero: "The validation engine for AI drug discovery". The homepage has no social share image and 11 images without alt text; it loads VWO (A/B testing), Microsoft Clarity, Google Analytics and LinkedIn, Bing and Meta ad tags.Source
• News coverageFirst-half 2026 results (August 18, 2026): revenue about US$404.2 million, up 27.3%; Life Science Group revenue about US$319.0 million, up 28.8%; Gene-to-Protein was about 66% of Life Science Group revenue and "the primary growth engine"; the AI-enabled drug discovery business "doubled year over year"; ProBio revenue up 34.2% and new orders up 54%. GenScript has about 6,165 employees and has served more than 200,000 customers in over 100 countries.Source
• News coverageGenScript and Tamarind Bio partnership (August 5, 2026): researchers on Tamarind Bio's AI design platform "can submit AI-generated sequences and access GenScript's end-to-end wet-lab services, including synthesis, expression, and testing", described as "a connected validation engine for AI-enabled discovery". In January 2026 GenScript was the wet-lab partner for Latent Labs' Latent-X2.Source
• HiringIntegrated Campaign Manager, Life Sciences Marketing (remote US, posted October 7, 2026) and a Marketing Campaigns Manager, International (same brief, still open): "transform business needs into marketing campaigns" with "omni-channel content development, and evaluation methods", "Build the storytelling of the GenScript LSG brand", and "Monitor the progress and analyze the effectiveness of marketing campaigns".Source

List which crawlers the firewall allows today. Explicitly allow the search and AI-assistant crawlers you want (Googlebot, Bingbot, OAI-SearchBot, PerplexityBot, ClaudeBot and similar) by their published IP ranges, serve robots.txt to everyone, and test monthly what the main assistants say about GenScript gene synthesis and AI validation.

Being cited in AI answers is now part of how scientists shortlist vendors, and it costs nothing if the crawlers can get in.

• More scraping

  Allow by verified IP range, not by user agent alone.

• Your websitePlain automated requests to genscript.com, including robots.txt, get HTTP 403 with "Automated access is not permitted." (checked October 21, 2026).Source
• News coverageGenScript and Tamarind Bio partnership (August 5, 2026): researchers on Tamarind Bio's AI design platform "can submit AI-generated sequences and access GenScript's end-to-end wet-lab services, including synthesis, expression, and testing", described as "a connected validation engine for AI-enabled discovery". In January 2026 GenScript was the wet-lab partner for Latent Labs' Latent-X2.Source
• Competitor researchRivals' own homepages: Twist Bioscience leads with sections for "AI Drug Discovery", "High-Throughput Screening" and "Complex Genes" and runs an "Invite your friends / Get rewarded" referral program; GENEWIZ from Azenta offers "Industry Leading Sequencing and Synthesis Service"; Thermo Fisher's Invitrogen GeneArt lets customers "Design, order, and track projects online"; IDT sells a "DNA synthesis platform".See the research Source

Use the FLASH Gene promise as the headline offer on the gene synthesis page, in paid search and LinkedIn ads, and in quote follow-up emails, with an "order now" path for sequences that qualify.

Speed and a fixed price remove the two biggest questions before a quote, and the guarantee lowers the risk of trying a new vendor.

• Longer genes do not qualify

  Show the length limits next to the price.

• News coverageFLASH Gene launch (June 2024): sequence to plasmid in "just four business days", "flat-rate pricing model starting at just $89, covering gene synthesis, cloning, and plasmid preparation", with guaranteed plasmid yield and "100% sequence accuracy".Source
• HiringIntegrated Campaign Manager, Life Sciences Marketing (remote US, posted October 7, 2026) and a Marketing Campaigns Manager, International (same brief, still open): "transform business needs into marketing campaigns" with "omni-channel content development, and evaluation methods", "Build the storytelling of the GenScript LSG brand", and "Monitor the progress and analyze the effectiveness of marketing campaigns".Source
• Competitor researchRivals' own homepages: Twist Bioscience leads with sections for "AI Drug Discovery", "High-Throughput Screening" and "Complex Genes" and runs an "Invite your friends / Get rewarded" referral program; GENEWIZ from Azenta offers "Industry Leading Sequencing and Synthesis Service"; Thermo Fisher's Invitrogen GeneArt lets customers "Design, order, and track projects online"; IDT sells a "DNA synthesis platform".See the research Source

Remove the zoom block, load only the first carousel slide upfront (or replace the carousel with one hero), serve modern image formats, and add alt text to the 11 images without it.

Small accessibility fixes help every visitor, and lighter images make the first screen appear faster on mobile.

• Design changes

  Keep the carousel but lazy-load slides 2 and later.

• Google PageSpeedHomepage on mobile: performance 29, 9.0 MB page weight (4.6 MB of images), lab Largest Contentful Paint 15.5 s on a carousel banner image, and about 4.1 MB of files served without efficient cache lifetimes. The homepage itself passes for real visitors (LCP 1.8 s), but the site as a whole fails Core Web Vitals: Largest Contentful Paint 2.7 s and Interaction to Next Paint 213 ms, with load time 13% slower than a year earlier. The viewport tag blocks zooming on phones.Source
• Your websiteHomepage title: "GenScript - Scripting Possibilities - The leader in molecular cloning and gene synthesis, peptide synthesis, protein and antibody engineering"; meta description: "a leading biotech company focusing exclusively on early drug discovery and development services"; hero: "The validation engine for AI drug discovery". The homepage has no social share image and 11 images without alt text; it loads VWO (A/B testing), Microsoft Clarity, Google Analytics and LinkedIn, Bing and Meta ad tags.Source

Restrict non-public hosts to the company network or login, add noindex to any that must stay reachable, request removal of the indexed copies in Search Console, and check every quarter which GenScript hosts appear in search.

Only the live pages should collect rankings and visitors; it also keeps work in progress private.

• Breaking testing workflows

  Give testers a login instead of open access.

• Search resultsGoogle results for GenScript gene synthesis pages include copies of genscript.com product pages served from a non-public development host as well as the live site.Source
• Your websiteHomepage title: "GenScript - Scripting Possibilities - The leader in molecular cloning and gene synthesis, peptide synthesis, protein and antibody engineering"; meta description: "a leading biotech company focusing exclusively on early drug discovery and development services"; hero: "The validation engine for AI drug discovery". The homepage has no social share image and 11 images without alt text; it loads VWO (A/B testing), Microsoft Clarity, Google Analytics and LinkedIn, Bing and Meta ad tags.Source

Publish a page for AI-first teams: upload hundreds of sequences in a file, choose expression and assays, get a quote and timeline in one step, and receive data in machine-readable formats. Offer an API for repeat customers and list design platforms that already connect.

Computational teams order in batches and want to stay in their tools; a direct path wins repeat volume that would otherwise go to rivals with an AI drug discovery section.

• Complex projects need scientists

  Route unusual requests to a technical account manager.

• News coverageGenScript and Tamarind Bio partnership (August 5, 2026): researchers on Tamarind Bio's AI design platform "can submit AI-generated sequences and access GenScript's end-to-end wet-lab services, including synthesis, expression, and testing", described as "a connected validation engine for AI-enabled discovery". In January 2026 GenScript was the wet-lab partner for Latent Labs' Latent-X2.Source
• HiringGlobal Product Manager, Emerging Applications (posted August 6, 2026): leads the "emerging applications portfolio", with "Exposure to AIDD, high-throughput screening, workflow automation, assay workflows, or data-driven discovery", and will "translate early market signals into product concepts, pilot programs, and go-to-market approaches".Source
• News coverageFirst-half 2026 results (August 18, 2026): revenue about US$404.2 million, up 27.3%; Life Science Group revenue about US$319.0 million, up 28.8%; Gene-to-Protein was about 66% of Life Science Group revenue and "the primary growth engine"; the AI-enabled drug discovery business "doubled year over year"; ProBio revenue up 34.2% and new orders up 54%. GenScript has about 6,165 employees and has served more than 200,000 customers in over 100 countries.Source
• Competitor researchRivals' own homepages: Twist Bioscience leads with sections for "AI Drug Discovery", "High-Throughput Screening" and "Complex Genes" and runs an "Invite your friends / Get rewarded" referral program; GENEWIZ from Azenta offers "Industry Leading Sequencing and Synthesis Service"; Thermo Fisher's Invitrogen GeneArt lets customers "Design, order, and track projects online"; IDT sells a "DNA synthesis platform".See the research Source

Start with one agent in the account area and chat: it reads order status, explains the current production step, gives the ship date and hands off to a person for anything else. Measure tickets deflected and satisfaction.

It frees technical staff for quotes and science, and customers get answers at any hour across time zones.

• Wrong dates

  Show only dates from the system, never estimates.

• HiringDigital roles: a Digital Experience Leader to "Set and monitor KPIs for digital experience quality, engagement, and conversion" and "Drive innovation in personalization, A/B testing, and user journey optimization", and an Enterprise AI Agent Development Engineer (posted September 30, 2026) to integrate AI agents "with enterprise systems, including ERP, CRM, OA, supply chain, and order management systems".Source
• HiringSales hiring across regions: a Sales Account Manager, Catalog Products for the Mid-Atlantic (Philadelphia; "30% of the time doing quote and lead follow-up", 70% in the field), Sales Account Managers for the Nordics, French-speaking Europe and Israel, Technical Account Managers in Malaysia and Taiwan, and a Technical Account Representative in the Netherlands who provides "accurate, customized quotations"; GenScript opened a production facility in Delft, Netherlands in 2025.Source
• Your websiteSite links from the homepage: webinars on lentivirus, cell-free mRNA templates, bispecific antibody manufacturing and CRISPR prime editing; customer case studies at /case-study; live chat; account sign-in and registration; a 30-day returns policy for catalog products.Source

Measure visit-to-quote and quote-to-order for gene synthesis, peptides, proteins, antibodies and cell lines. Test one change per month per page: shorter forms, instant price for standard cases, saved sequences, and a clear turnaround promise.

Small gains on the busiest quote paths compound across 200,000 customers.

• Too little traffic on some pages

  Test sitewide components instead.

• HiringDigital roles: a Digital Experience Leader to "Set and monitor KPIs for digital experience quality, engagement, and conversion" and "Drive innovation in personalization, A/B testing, and user journey optimization", and an Enterprise AI Agent Development Engineer (posted September 30, 2026) to integrate AI agents "with enterprise systems, including ERP, CRM, OA, supply chain, and order management systems".Source
• Google PageSpeedGene synthesis service page on mobile (PageSpeed, October 21, 2026): performance 28, 7.9 MB, Largest Contentful Paint 11.8 s and 10.1 s of blocked main thread in the lab. Real visitors fail Core Web Vitals: Largest Contentful Paint 3.0 s and Interaction to Next Paint 264 ms at the 75th percentile. The live-chat widget (including a voice-calling module) is the largest script cost, about 6 seconds of script time and 1.5 MB of unused code, followed by an embedded YouTube player loaded with the page.Source
• Your websiteHomepage title: "GenScript - Scripting Possibilities - The leader in molecular cloning and gene synthesis, peptide synthesis, protein and antibody engineering"; meta description: "a leading biotech company focusing exclusively on early drug discovery and development services"; hero: "The validation engine for AI drug discovery". The homepage has no social share image and 11 images without alt text; it loads VWO (A/B testing), Microsoft Clarity, Google Analytics and LinkedIn, Bing and Meta ad tags.Source
• News coverageFLASH Gene launch (June 2024): sequence to plasmid in "just four business days", "flat-rate pricing model starting at just $89, covering gene synthesis, cloning, and plasmid preparation", with guaranteed plasmid yield and "100% sequence accuracy".Source

Build a Europe page and campaign: what is made in Delft, typical delivery times to each country, local support and invoicing, in English, French and German. Equip the regional sales hires with the same story.

Local production answers the first objection European buyers raise about a US or Asian supplier.

• Not every service is local

  State clearly what ships from where.

• HiringSales hiring across regions: a Sales Account Manager, Catalog Products for the Mid-Atlantic (Philadelphia; "30% of the time doing quote and lead follow-up", 70% in the field), Sales Account Managers for the Nordics, French-speaking Europe and Israel, Technical Account Managers in Malaysia and Taiwan, and a Technical Account Representative in the Netherlands who provides "accurate, customized quotations"; GenScript opened a production facility in Delft, Netherlands in 2025.Source
• HiringIntegrated Campaign Manager, Life Sciences Marketing (remote US, posted October 7, 2026) and a Marketing Campaigns Manager, International (same brief, still open): "transform business needs into marketing campaigns" with "omni-channel content development, and evaluation methods", "Build the storytelling of the GenScript LSG brand", and "Monitor the progress and analyze the effectiveness of marketing campaigns".Source
• News coverageFirst-half 2026 results (August 18, 2026): revenue about US$404.2 million, up 27.3%; Life Science Group revenue about US$319.0 million, up 28.8%; Gene-to-Protein was about 66% of Life Science Group revenue and "the primary growth engine"; the AI-enabled drug discovery business "doubled year over year"; ProBio revenue up 34.2% and new orders up 54%. GenScript has about 6,165 employees and has served more than 200,000 customers in over 100 countries.Source

Each Monday, send each account manager the quotes in their territory older than 7 days without an order, with the product, value and a suggested next step. Track conversion of followed-up quotes.

Following up open quotes is the fastest revenue a field rep can find.

• Too many quotes

  Rank by value and recency.

• HiringSales hiring across regions: a Sales Account Manager, Catalog Products for the Mid-Atlantic (Philadelphia; "30% of the time doing quote and lead follow-up", 70% in the field), Sales Account Managers for the Nordics, French-speaking Europe and Israel, Technical Account Managers in Malaysia and Taiwan, and a Technical Account Representative in the Netherlands who provides "accurate, customized quotations"; GenScript opened a production facility in Delft, Netherlands in 2025.Source
• HiringDigital roles: a Digital Experience Leader to "Set and monitor KPIs for digital experience quality, engagement, and conversion" and "Drive innovation in personalization, A/B testing, and user journey optimization", and an Enterprise AI Agent Development Engineer (posted September 30, 2026) to integrate AI agents "with enterprise systems, including ERP, CRM, OA, supply chain, and order management systems".Source

Write short anonymized stories by modality (plasmids, antibodies, cell and gene therapy) with timelines from contract to IND, and use them as the core of each ProBio campaign and on GenScript's related service pages.

IND-level proof is the strongest signal a CDMO can show, and it lets discovery customers see a path to production.

• Confidentiality

  Anonymize and use ranges.

• HiringSr. Marketing Manager for ProBio, GenScript's CDMO (UK, posted September 24, 2026): "Map customer journeys and ensure marketing activities support customers at each stage of the buying process"; campaigns "that drive awareness, engagement, pipeline, and revenue growth". ProBio "has helped customers ... obtain more than 150 IND approvals since October 2017".Source
• News coverageFirst-half 2026 results (August 18, 2026): revenue about US$404.2 million, up 27.3%; Life Science Group revenue about US$319.0 million, up 28.8%; Gene-to-Protein was about 66% of Life Science Group revenue and "the primary growth engine"; the AI-enabled drug discovery business "doubled year over year"; ProBio revenue up 34.2% and new orders up 54%. GenScript has about 6,165 employees and has served more than 200,000 customers in over 100 countries.Source

Add one optional question after catalog checkout ("What did you need that you could not find?"), tag answers monthly, and interview 20 respondents a quarter.

A steady stream of real requests grounds portfolio bets in demand.

• Few answers

  Also ask in quote follow-up emails.

• HiringStrategic Product Manager, Biotech Reagents Portfolio (posted September 15, 2026): will "define WHAT products GenScript should build over the next 3-5 years" across antibodies, recombinant proteins, enzymes, bioassays and cell and gene therapy reagents, using "Jobs-to-be-Done (JTBD), and Voice of the Customer (VOC)".Source
• Your websiteSite links from the homepage: webinars on lentivirus, cell-free mRNA templates, bispecific antibody manufacturing and CRISPR prime editing; customer case studies at /case-study; live chat; account sign-in and registration; a 30-day returns policy for catalog products.Source

For each webinar, publish the recording, a summary article, three short clips and a related protocol download on the matching service page, and promote them in the campaign calendar.

Evergreen technical content keeps generating leads and search traffic long after the event.

• Outdated science

  Date each asset and review yearly.

• Your websiteSite links from the homepage: webinars on lentivirus, cell-free mRNA templates, bispecific antibody manufacturing and CRISPR prime editing; customer case studies at /case-study; live chat; account sign-in and registration; a 30-day returns policy for catalog products.Source
• HiringIntegrated Campaign Manager, Life Sciences Marketing (remote US, posted October 7, 2026) and a Marketing Campaigns Manager, International (same brief, still open): "transform business needs into marketing campaigns" with "omni-channel content development, and evaluation methods", "Build the storytelling of the GenScript LSG brand", and "Monitor the progress and analyze the effectiveness of marketing campaigns".Source

Offer an annual capacity plan: a reserved number of constructs, expressions and assays per month at a fixed price, with a shared dashboard and data in model-ready formats. Pilot with five customers.

Reserved capacity locks in volume, smooths production planning and makes switching costly for rivals.

• Unused capacity

  Allow rollover for one month.

• News coverageGenScript and Tamarind Bio partnership (August 5, 2026): researchers on Tamarind Bio's AI design platform "can submit AI-generated sequences and access GenScript's end-to-end wet-lab services, including synthesis, expression, and testing", described as "a connected validation engine for AI-enabled discovery". In January 2026 GenScript was the wet-lab partner for Latent Labs' Latent-X2.Source
• HiringGlobal Product Manager, Emerging Applications (posted August 6, 2026): leads the "emerging applications portfolio", with "Exposure to AIDD, high-throughput screening, workflow automation, assay workflows, or data-driven discovery", and will "translate early market signals into product concepts, pilot programs, and go-to-market approaches".Source
• News coverageFirst-half 2026 results (August 18, 2026): revenue about US$404.2 million, up 27.3%; Life Science Group revenue about US$319.0 million, up 28.8%; Gene-to-Protein was about 66% of Life Science Group revenue and "the primary growth engine"; the AI-enabled drug discovery business "doubled year over year"; ProBio revenue up 34.2% and new orders up 54%. GenScript has about 6,165 employees and has served more than 200,000 customers in over 100 countries.Source

Offer a standard ordering API and revenue share to design platforms and open-source tools, starting with three widely used platforms, and co-market each launch.

Being the default lab behind design tools turns them into a sales channel.

• Partners favor rivals

  Compete on turnaround and data quality.

• News coverageGenScript and Tamarind Bio partnership (August 5, 2026): researchers on Tamarind Bio's AI design platform "can submit AI-generated sequences and access GenScript's end-to-end wet-lab services, including synthesis, expression, and testing", described as "a connected validation engine for AI-enabled discovery". In January 2026 GenScript was the wet-lab partner for Latent Labs' Latent-X2.Source
• Competitor researchRivals' own homepages: Twist Bioscience leads with sections for "AI Drug Discovery", "High-Throughput Screening" and "Complex Genes" and runs an "Invite your friends / Get rewarded" referral program; GENEWIZ from Azenta offers "Industry Leading Sequencing and Synthesis Service"; Thermo Fisher's Invitrogen GeneArt lets customers "Design, order, and track projects online"; IDT sells a "DNA synthesis platform".See the research Source
• HiringGlobal Product Manager, Emerging Applications (posted August 6, 2026): leads the "emerging applications portfolio", with "Exposure to AIDD, high-throughput screening, workflow automation, assay workflows, or data-driven discovery", and will "translate early market signals into product concepts, pilot programs, and go-to-market approaches".Source

With customer consent, release a curated, anonymized benchmark of designs and measured expression and binding, updated twice a year, with a leaderboard for model builders.

It positions GenScript as the reference lab for AI drug discovery and draws every new AI team to its door.

• Customer IP

  Only data customers release.

• News coverageGenScript and Tamarind Bio partnership (August 5, 2026): researchers on Tamarind Bio's AI design platform "can submit AI-generated sequences and access GenScript's end-to-end wet-lab services, including synthesis, expression, and testing", described as "a connected validation engine for AI-enabled discovery". In January 2026 GenScript was the wet-lab partner for Latent Labs' Latent-X2.Source
• News coverageFirst-half 2026 results (August 18, 2026): revenue about US$404.2 million, up 27.3%; Life Science Group revenue about US$319.0 million, up 28.8%; Gene-to-Protein was about 66% of Life Science Group revenue and "the primary growth engine"; the AI-enabled drug discovery business "doubled year over year"; ProBio revenue up 34.2% and new orders up 54%. GenScript has about 6,165 employees and has served more than 200,000 customers in over 100 countries.Source
• HiringGlobal Product Manager, Emerging Applications (posted August 6, 2026): leads the "emerging applications portfolio", with "Exposure to AIDD, high-throughput screening, workflow automation, assay workflows, or data-driven discovery", and will "translate early market signals into product concepts, pilot programs, and go-to-market approaches".Source

Give each account a referral link: the new lab gets a credit on its first gene order and the referrer gets account credit. Promote it in order confirmation emails.

Peer recommendations carry weight in labs, and alumni moving to new labs are natural ambassadors.

• Institution gift rules

  Credit to the lab account, not the person.

• Competitor researchRivals' own homepages: Twist Bioscience leads with sections for "AI Drug Discovery", "High-Throughput Screening" and "Complex Genes" and runs an "Invite your friends / Get rewarded" referral program; GENEWIZ from Azenta offers "Industry Leading Sequencing and Synthesis Service"; Thermo Fisher's Invitrogen GeneArt lets customers "Design, order, and track projects online"; IDT sells a "DNA synthesis platform".See the research Source
• Your websiteSite links from the homepage: webinars on lentivirus, cell-free mRNA templates, bispecific antibody manufacturing and CRISPR prime editing; customer case studies at /case-study; live chat; account sign-in and registration; a 30-day returns policy for catalog products.Source

When a gene ships, send a short email with the next service that fits (expression, purification, antibody), a pre-filled quote with the sequence already on file, and a technical contact.

Removing re-entry of the sequence makes the next order the easy choice.

• Sequence privacy

  Only pre-fill inside the logged-in account.

• News coverageFirst-half 2026 results (August 18, 2026): revenue about US$404.2 million, up 27.3%; Life Science Group revenue about US$319.0 million, up 28.8%; Gene-to-Protein was about 66% of Life Science Group revenue and "the primary growth engine"; the AI-enabled drug discovery business "doubled year over year"; ProBio revenue up 34.2% and new orders up 54%. GenScript has about 6,165 employees and has served more than 200,000 customers in over 100 countries.Source
• HiringSales hiring across regions: a Sales Account Manager, Catalog Products for the Mid-Atlantic (Philadelphia; "30% of the time doing quote and lead follow-up", 70% in the field), Sales Account Managers for the Nordics, French-speaking Europe and Israel, Technical Account Managers in Malaysia and Taiwan, and a Technical Account Representative in the Netherlands who provides "accurate, customized quotations"; GenScript opened a production facility in Delft, Netherlands in 2025.Source

Film one-minute videos of each step of FLASH Gene and protein production, with the scientists who run them, and use them on service pages and LinkedIn.

Seeing the automation backs up the speed claims and humanizes a large supplier.

• Slows pages

  Load videos only on click.

• News coverageFLASH Gene launch (June 2024): sequence to plasmid in "just four business days", "flat-rate pricing model starting at just $89, covering gene synthesis, cloning, and plasmid preparation", with guaranteed plasmid yield and "100% sequence accuracy".Source
• HiringSales hiring across regions: a Sales Account Manager, Catalog Products for the Mid-Atlantic (Philadelphia; "30% of the time doing quote and lead follow-up", 70% in the field), Sales Account Managers for the Nordics, French-speaking Europe and Israel, Technical Account Managers in Malaysia and Taiwan, and a Technical Account Representative in the Netherlands who provides "accurate, customized quotations"; GenScript opened a production facility in Delft, Netherlands in 2025.Source
• Your websiteHomepage title: "GenScript - Scripting Possibilities - The leader in molecular cloning and gene synthesis, peptide synthesis, protein and antibody engineering"; meta description: "a leading biotech company focusing exclusively on early drug discovery and development services"; hero: "The validation engine for AI drug discovery". The homepage has no social share image and 11 images without alt text; it loads VWO (A/B testing), Microsoft Clarity, Google Analytics and LinkedIn, Bing and Meta ad tags.Source